Comprehensive Transcriptional Analysis of Early-Stage Urothelial CarcinomaJakob Hedegaard, Lars Dyrskjøt, Michael Borre et al.|Cancer Cell|2016Cited by 654
An integrated multi-omics analysis identifies prognostic molecular subtypes of non-muscle-invasive bladder cancerSia V. Lindskrog, Lars Dyrskjøt, Frederik Prip et al.|Nature Communications|2021Cited by 381
Validation of a DNA Methylation-Mutation Urine Assay to Select Patients with Hematuria for CystoscopyKim E.M. van Kessel, Ellen C. Zwarthoff, Willemien Beukers et al.|The Journal of Urology|2016Cited by 154
Prognostic Impact of a 12-gene Progression Score in Non–muscle-invasive Bladder Cancer: A Prospective Multicentre Validation StudyLars Dyrskjøt, Torben F. Ørntoft, Thomas Reinert et al.|European Urology|2017Cited by 100
<i>FGFR3</i> , <i>TERT</i> and <i>OTX1</i> as a Urinary Biomarker Combination for Surveillance of Patients with Bladder Cancer in a Large Prospective Multicenter StudyWillemien Beukers, Ellen C. Zwarthoff, Kirstin A. van der Keur et al.|The Journal of Urology|2017Cited by 92